Home > News > NCL to go into labs with ‘Golden Triangle’ for cancer trials
May 30th, 2005
NCL to go into labs with ‘Golden Triangle’ for cancer trials
Eight months after raising hopes with their cutting edge ‘Golden Triangle’ technology for fighting cancer sans chemotherapy, nanoscientists at the National Chemical Laboratory (NCL) are gearing up for the technology’s first in-vitro tests.
The trials are being conducted to establish the toxicity of the gold nano-particles. "While gold is inherently non-toxic, we have to see exactly where the nano-sized triangles go when introduced into the cancerous area. We have kept a two-year window to see if we can get into clinical trials on humans."
National Chemical Laboratory
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Conference Scheduled June 5-7 on Safe Use of Nanotechnology in Environmental Remediation May 23rd, 2013
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013